Differential serum dynamics of apelin, elabela, and angiotensinogen in CKD and haemodialysis: insights into peptide modulation across the dialysis procedure
These findings highlight distinct, peptide-specific responses to HD and support a context-dependent interplay between uremic burden, peptide systems, and dialysis-induced shifts. Apelinergic and RAS peptides may represent promising biomarkers of intradialytic cardiovascular modulation. Further studies are warranted to explore their prognostic and therapeutic implications in CKD.
Authors
- Mariusz Suwała (ORCID: https://orcid.org/0000-0002-5192-3353)
- Marcin Lisak (ORCID: https://orcid.org/0000-0002-3881-7783)
- Natalia Serwin (ORCID: https://orcid.org/0000-0002-1769-2037)
- Bartosz Wojciuk (ORCID: https://orcid.org/0000-0002-2990-0323)
- Bartłomiej Grygorcewicz (ORCID: https://orcid.org/0000-0002-0593-0069)
- Martyna Opara-Bajerowicz
- Karol Serwin (ORCID: https://orcid.org/0000-0002-1071-8337)
- Aleksandra Gomółka
- Adrianna Jerzyk
- Aleksandra Cader-Ptak
- Mateusz Cejko
- Elżbieta Cecerska-Heryć
- Emilia Spajzer
- Aleksandra Manelska
- Paulina Woźniak
- Kacper Ćwikła
- Katarzyna Bąk
- Barbara Dołęgowska
- Magda Wiśniewska
Institutions
- Pomeranian Medical University (PL)
Publication Details
- Journal
- Renal Failure
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1080/0886022x.2026.2646404
- Primary Topic
- Apelin-related biomedical research
- Type
- article
- Field-Weighted Citation Impact
- 0.00